|
| 36717589 | Salmonella effector SopB reorganizes cytoskeletal vimentin to maintain replication vacuoles for efficient infection. | | 2023 |
| 35074346 | Toll-like receptor 2 and 6 agonist fibroblast-stimulating lipopeptide increases expression and secretion of CXCL1 and CXCL2 by uveal melanocytes. | Exp Eye Res | 2022 |
| 35780579 | PLK inhibitors identified by high content phenotypic screening promote maturation of human PSC-derived cardiomyocytes. | Biochemical and Biophysical Research Communications | 2022 |
| 34824220 | High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer. | Nat Commun | 2021 |
| 33634131 | Multifaceted Function of Myosin-18, an Unconventional Class of the Myosin Superfamily. | Frontiers in Cell and Developmental Biology | 2021 |
| 34253580 | Multiplex Tissue Imaging Harmonization: A Multicenter Experience from CIMAC-CIDC Immuno-Oncology Biomarkers Network. | Clin Cancer Res | 2021 |
| 33979551 | Cultured Human Uveal Melanocytes Express/secrete CXCL1 and CXCL2 Constitutively and Increased by Lipopolysaccharide via Activation of Toll-like Receptor 4. | Curr Eye Res | 2021 |
| 34301793 | AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway-Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase B. | Cancer Discov | 2021 |
| 32397839 | Quantitative Study of Human Scleral Melanocytes and Their Topographical Distribution. | Curr Eye Res | 2020 |
| 31186138 | miR-199a-3p promotes cardiomyocyte proliferation by inhibiting Cd151 expression. | Biochemical and Biophysical Research Communications | 2019 |
| 29358171 | Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer. | Cancer Res | 2018 |
| 28504649 | Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth. | J Clin Invest | 2017 |
| 27783536 | Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases. | Endocrinology | 2016 |
| 26971997 | USP7 Enforces Heterochromatinization of p53 Target Promoters by Protecting SUV39H1 from MDM2-Mediated Degradation. | Cell Reports | 2016 |
| 27453044 | CRISPR-Barcoding for Intratumor Genetic Heterogeneity Modeling and Functional Analysis of Oncogenic Driver Mutations. | Molecular Cell | 2016 |
| 24702180 | Coactivator MYST1 regulates nuclear factor-κB and androgen receptor functions during proliferation of prostate cancer cells. | Molecular Endocrinology | 2014 |
| 23649620 | Androgens up-regulate transcription of the Notch inhibitor Numb in C2C12 myoblasts via Wnt/β-catenin signaling to T cell factor elements in the Numb promoter. | Journal of Biological Chemistry | 2013 |
| 22700758 | Nandrolone, an anabolic steroid, stabilizes Numb protein through inhibition of mdm2 in C2C12 myoblasts. | | 2012 |
| 22082367 | Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation. | Annals of the New York Academy of Sciences | 2011 |
| 21131838 | Loss of p16INK4A expression in low-grade ovarian serous carcinomas. | International Journal of Gynecological Pathology | 2011 |
| 21575861 | High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/β-catenin target gene, CDC25A. | Cancer Cell | 2011 |
| 21945932 | Nandrolone reduces activation of Notch signaling in denervated muscle associated with increased Numb expression. | Biochemical and Biophysical Research Communications | 2011 |
| 20227393 | Prostaglandin E2 modulates components of the Wnt signaling system in bone and prostate cancer cells. | Biochemical and Biophysical Research Communications | 2010 |
| 19384952 | Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells. | Int J Cancer | 2009 |
| 18316605 | Clonal selection in malignant transformation of human fibroblasts transduced with defined cellular oncogenes. | Cancer Research | 2008 |
| 17297474 | In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma. | Oncogene | 2007 |
| 17646262 | Androgens promote preosteoblast differentiation via activation of the canonical Wnt signaling pathway. | Annals of the New York Academy of Sciences | 2007 |
| 17575141 | Androgen-induced Wnt signaling in preosteoblasts promotes the growth of MDA-PCa-2b human prostate cancer cells. | Cancer Research | 2007 |
| 16778100 | Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination. | Clin Cancer Res | 2006 |
| 16123118 | Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones. | Carcinogenesis | 2006 |
| 17027522 | The role of the interleukin-6/gp130 signaling pathway in bone metabolism. | Vitamins and Hormones | 2006 |
| 16831922 | Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG/RANKL/RANK system. | Annals of the New York Academy of Sciences | 2006 |
| 15618359 | Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system. | Endocrinology | 2005 |
| 15550400 | Cyclooxygenase-2 suppresses hypoxia-induced apoptosis via a combination of direct and indirect inhibition of p53 activity in a human prostate cancer cell line. | Journal of Biological Chemistry | 2005 |
| 15994951 | Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread. | Cancer Res | 2005 |
| 12873977 | BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma. | Cancer Res | 2003 |
| 12401798 | Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line. | Journal of Biological Chemistry | 2002 |
| 11779161 | Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway. | Biochemical and Biophysical Research Communications | 2002 |
| 11502467 | The role of cyclooxygenase-2 in prostate cancer. | Urology | 2001 |
| 10999846 | Immunohistochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the human fetal and adult male reproductive tracts. | Journal of Clinical Endocrinology and Metabolism | 2000 |
| 10891341 | Molecular cloning, expression, and functional characterization of a novel member of the CD38 family of ADP-ribosyl cyclases. | Biochemical and Biophysical Research Communications | 2000 |
| 11018637 | Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate. | Urology | 2000 |
| 10953162 | Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. | Journal of Urology | 2000 |
| 10851319 | MUC1 Expression in Prostate Carcinoma: Correlation with Grade and Stage. | Molecular Urology | 1999 |
| 10919714 | Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. | Clinical and Experimental Metastasis | 1999 |
| 9766645 | NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. | Cancer Research | 1998 |